We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2897:TSENissin Foods Holdings Co., Ltd. Analysis

Data as of 2026-03-14 - not real-time

¥2,920.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Price action: Nissin Foods is trading at ¥2,920.5, which sits below the 20‑day SMA of ¥3,161.8 and the 50‑day SMA of ¥3,097.5, but just under the 200‑day SMA of ¥2,923.5, indicating a short‑term pull‑back within a longer‑term uptrend. The RSI of 30.4 points to an oversold condition, while the MACD remains bearish with a widening negative histogram, and volume is on an increasing trend, supporting a potential near‑term bounce off the technical support at ¥2,901.5. The market sentiment gauge shows a “Greed” reading of 72.9, suggesting bullish bias despite the technical softness.
Fundamentals & valuation: The company delivers 4.5% revenue growth, a solid dividend yield of 2.4% with a 42% payout ratio, and a trailing PE of 17.7 (forward PE 14.1). However, free cash flow is negative (‑¥26.3 bn) and debt‑to‑equity is high at 35.3, while the DCF‑derived fair value of ¥2,624 is below the current price, implying a modest premium. Low beta (≈0.03) limits market‑wide volatility exposure, yet 30‑day price volatility is elevated at 27%, and analyst consensus remains a “Buy” with an upside/downside potential of ~17%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD despite oversold RSI
  • Price trading below short‑term moving averages
  • Increasing volume supporting potential stabilization

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive dividend yield and moderate payout ratio
  • Revenue growth and forward PE compression
  • Technical support level near current price offering downside cushion

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Defensive consumer staple positioning with strong brand equity
  • High debt load and negative free cash flow limiting cash generation
  • Valuation premium relative to DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth4.50%
Profit Margin6.46%
P/E Ratio17.7
ROE10.30%
ROA3.70%
Debt/Equity35.26
P/B Ratio1.7
Op. Cash Flow¥73.5B
Free Cash Flow¥-26251999232

Technical Analysis

TrendBullish
RSI30.4
Support¥2,901.50
Resistance¥3,354.00
MA 20¥3,161.80
MA 50¥3,097.54
MA 200¥2,923.48
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value¥2,623.95
Target Price¥3,436.36
Upside/Downside17.66%
GradeOvervalued
TypeBlend
Dividend Yield2.40%

Risk Assessment

Beta0.03
Volatility27.41%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.